INS and atrial fibrillation: Telmisartan was prescribed in two studies [8, 10], which might contribute to its AF-preventive effect through its insulin-sensitizing effect and the attenuation of AF-promoting atrial remodeling related to peroxisome proliferator-activated receptor gamma stimulation.